Gene · 406885
Papers3,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum microRNA Profiles and Pathways in Hepatitis B-Associated Hepatocellular Carcinoma: A South African Study. | Int J Mol Sci | 2024 | 38256049 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Graft Rejection or Tolerance Biomarkers and Their Dilemma in Clinical Routines Behaving like Devilish, Angelic, or Frightening Elements. | Biomedicines | 2024 | 38255221 | PubTator, text mining | PubMed |
| From Churchill to Elephants: The Role of Protective Genes against Cancer. | Genes (Basel) | 2024 | 38255007 | PubTator, text mining | PubMed |
| Small noncoding RNAs and sperm nuclear basic proteins reflect the environmental impact on germ cells. | Mol Med | 2024 | 38243211 | PubTator, text mining | PubMed |
| Growth-suppressor microRNAs mediate synaptic overgrowth and behavioral deficits in Fragile X mental retardation protein deficiency. | iScience | 2024 | 38235335 | PubTator, text mining | PubMed |
| HCC-Related lncRNAs: Roles and Mechanisms. | Int J Mol Sci | 2024 | 38203767 | PubTator, text mining | PubMed |
| Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy. | J Clin Med | 2024 | 38202299 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
| Pyroptosis-related signatures predict immune characteristics and prognosis in IPF. | Heliyon | 2024 | 38192798 | PubTator, text mining | PubMed |
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles in Cancer Therapy Resistance: from Biology to Clinical Opportunity. | Int J Biol Sci | 2024 | 38164177 | PubTator, text mining | PubMed |
| TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma. | medRxiv | 2024 | 37398275 | PubTator, text mining | PubMed |
| MicroRNA profile of extracellular vesicles released by Müller glial cells. | Front Cell Neurosci | 2023 | 38303973 | PubTator, text mining | PubMed |
| Mitochondrial-related microRNAs and their roles in cellular senescence. | Front Physiol | 2023 | 38250662 | PubTator, text mining | PubMed |
| PCR Array Profiling of miRNA Expression Involved in the Differentiation of Amniotic Fluid Stem Cells toward Endothelial and Smooth Muscle Progenitor Cells. | Int J Mol Sci | 2023 | 38203477 | PubTator, text mining | PubMed |
| Clinical Biofluid Assays for Prostate Cancer. | Cancers (Basel) | 2023 | 38201592 | PubTator, text mining | PubMed |
| An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed. | Front Cardiovasc Med | 2023 | 38179503 | PubTator, text mining | PubMed |
| Implications of oral dysbiosis and HPV infection in head and neck cancer: from molecular and cellular mechanisms to early diagnosis and therapy. | Front Oncol | 2023 | 38179168 | PubTator, text mining | PubMed |
| Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities. | Front Oncol | 2023 | 38170015 | PubTator, text mining | PubMed |
| Liquid biopsy in ovarian cancer in China and the world: current status and future perspectives. | Front Oncol | 2023 | 38169730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406885/papers?page=5